Latest news
Arcturus and CSL Seqirus terminate sa-mRNA vaccine partnership - AllSciAllSci · Fri, 07 Aug 2026 16:13:37 GMTBioMarin drops BMN 401 following unsuccessful pivotal trial - AllSciAllSci · Fri, 07 Aug 2026 16:01:43 GMTShape and Rett Syndrome Research Trust advance AI-designed RNA editor for R168X mutation - AllSciAllSci · Fri, 07 Aug 2026 15:03:13 GMTTarsus secures USD 125m to fund Alkeus acquisition and expand eye care pipeline - AllSciAllSci · Fri, 07 Aug 2026 14:59:09 GMTReCode expands cystic fibrosis gene editing push with new CF Foundation backing and unnamed partner - AllSciAllSci · Fri, 07 Aug 2026 13:54:55 GMTBiogen closes deal for USD 1b buyout of RayThera - AllSciAllSci · Fri, 07 Aug 2026 13:52:15 GMTLatigo raises USD 345.6m in upsized IPO backed by Nav1.8 Phase II data - AllSciAllSci · Fri, 07 Aug 2026 13:30:11 GMTTranscenta sells CDMO assets to WuXi Bio to focus on drug pipeline - AllSciAllSci · Fri, 07 Aug 2026 13:23:56 GMT